Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- New data presented today at the 55(th) Annual Meeting of the European Association for the Study of Diabetes (EASD) showed ...
Lees verderFROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 15, 2019 /PRNewswire/ -- Significant advances in the global search for blood test technologies ...
Lees verderResearch demonstrates clinical accuracy of OneTouch Select Plus® platform, and demonstrates the value of a continuous and systematic testing program to verify product ...
Lees verderPlus: - Genomic Analysis of Alzheimer's Study May Enable a Precision Medicine Approach CHICAGO, July 25, 2018 /PRNewswire/ -- Significant reductions in the risk of mild ...
Lees verderCONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN'S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY CHICAGO, July 25, 2018 /PRNewswire/ -- The first ...
Lees verderBAGSVÆRD, Denmark, June 23, 2018 /PRNewswire/ -- Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy(R) (insulin degludec and liraglutide injection) ...
Lees verderORLANDO, Florida, June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood ...
Lees verderORLANDO, Florida, June 23, 2018 /PRNewswire/ -- Adults with type 2 diabetes treated with Tresiba(R) (insulin degludec injection) had a significant reduction in HbA1c and a 30% ...
Lees verderPublished findings show initial testing for three specific biomarkers may provide superior results over standard screening methods BREA, California, June 19, 2018 /PRNewswire/ ...
Lees verderABU DHABI, UAE, December 7, 2017 /PRNewswire/ -- In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate ...
Lees verder